NSETrading Window26 Jun 2026 · 26 Jun 2026, 10:05 am
Trading Window
Torrent Pharmaceuticals Limited · TORNTPHARM
✦ AI Summary
Torrent Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Torrent Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
TORNTPHARM_26062026100459_SE_Intimation_Trading_window_Q1.pdf
View document text
26th June, 2026
The Dy. General Manager (Listing Dept.) The Manager – Listing Dept.,
BSE Limited., National Stock Exchange of India Ltd.,
Corporate Relationship Dept., Exchange Plaza, 5th Floor,
1st Floor, New Trading Ring, Plot No. C/1, G. Block,
P. J. Towers, Dalal Street, Fort, Bandra - Kurla Complex, Bandra (E),
Mumbai - 400 001 Mumbai – 400 051
(BSE Scrip Code: 500420) (NSE Scrip Code: TORNTPHARM)
Dear Sir,
Sub.: Intimation of the Closure of Trading Window as per Company's Code of Conduct to
Regulate, Monitor and Report Trading by Designated Persons
Pursuant to Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons of
the Company ('Code') and applicable SEBI Regulations, we would like to inform you that trading
window for dealing in securities of the Company by Designated Persons stands closed from
1st July, 2026 and will be re-opened 48 hours after the submission of the Financial Results for the
Quarter ended 30th June, 2026 to the Stock Exchanges.
Kindly take note of the above.
Thanking you,
Yours sincerely,
For TORRENT PHARMACEUTICALS LIMITED
CHINTAN M. TRIVEDI
COMPANY SECRETARY
Email – investorservices@torrentpharma.com